TCL Archive In Brief: Six On NCA Serve Out Terms, No Successors in Sights DCBD Renamed With ‘Centers’ In Title February 9, 1990
TCL Archive BRCA 1 Mutation Finding Draws Attention To Potential Perils Of Genetic Testing October 6, 1995
TCL Archive FDA approves a new cancer drug, Vidaza, and two sNDAs, without going to ODAC. A date with ODAC may signal a weak case for drug approval, recent approval data indicate. May 28, 2004
